TROP2-EXPRESSING SOLID TUMORS

Clinical trials for TROP2-EXPRESSING SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new TROP2-EXPRESSING SOLID TUMORS trials appear

Sign up with your email to follow new studies for TROP2-EXPRESSING SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New 'Off-the-Shelf' cell therapy takes on Hard-to-Treat cancers

Disease control Recruiting now

This study tests a new treatment called EB-NK-301 for adults with advanced solid tumors that have stopped responding to standard therapies. EB-NK-301 uses specially engineered immune cells (CAR NK cells) to target a protein called TROP2 on cancer cells. The main goals are to chec…

Matched conditions: TROP2-EXPRESSING SOLID TUMORS

Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated May 26, 2026 07:25 UTC

TROP2-EXPRESSING SOLID TUMORS

Get alerted when new TROP2-EXPRESSING SOLID TUMORS trials appear

New 'Off-the-Shelf' cell therapy takes on Hard-to-Treat cancers